Business
CSL open to new manufacturing options after AstraZeneca production – Sydney Morning Herald
The biotech giant says it can hit the 50 million dose mark by December and is in talks with the government about how else it can help fight the pandemic.
Biotech giant CSL is in talks with the government about its longer-term role in Australias fight against coronavirus, as the company races to complete 50 million doses of the AstraZeneca vaccine by December.
The $123 billion blood plasma giant confirmed over the weekend that it was now producing more than 1 million doses of the vaccine per week, with more than 3.7 million doses released to the public by the end of April. There is a four-week quality control and approvals process that must be completed…
-
Noosa News23 hours agoMeasles alert issued south of Brisbane after traveller tests positive
-
General23 hours agoArtists brace as AI, the greatest theft in history, swamps us now
-
General24 hours agoMother and son facing trial for kidnapping her two younger sons appear in ACT Supreme Court
-
Business10 hours agoWarning! These ASX 200 shares were just downgraded